Literature DB >> 24953204

Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age.

Umberto Vespasiani-Gentilucci1, Paolo Gallo2, Gaetano Piccinocchi3, Roberto Piccinocchi3, Emiliano Schena4, Giovanni Galati2, Antonio De Vincentis2, Chiara Dell'Unto2, Antonio Picardi2.   

Abstract

BACKGROUND: Determinants of alanine aminotransferase levels have never been investigated in real-life settings. The relationship between alanine aminotransferase and age remains controversial. We evaluated epidemiological, anthropometric, and metabolic factors associated with alanine aminotransferase, focusing on the relationship between alanine aminotransferase and age.
METHODS: A 5-year retrospective analysis was performed on data recorded by 120 general practitioners from Naples (Italy), caring for 170,000 subjects. Exclusion criteria were age <18 years, diagnosis of chronic liver disease, positive markers for viral hepatitis, alcohol abuse, and alanine aminotransferase >100UI/L.
RESULTS: 44,232 subjects were enrolled (42.7% males, mean age 56±18 years). Alanine aminotransferase showed independent direct associations with body mass index, glycaemia, cholesterol, and triglycerides (p<0.001), and inverse associations with high-density lipoprotein cholesterol (p<0.001) and creatinine (p<0.01). The relationship between alanine aminotransferase and age was better expressed by polynomial regression (r=0.18, p<0.001), creating an inverted parabola. Mean alanine aminotransferase increased until the third decade in males and the fifth in females, with a subsequent progressive decrease in both genders. The inverse association between alanine aminotransferase and age in older subjects was independent from metabolic factors.
CONCLUSIONS: This real-life setting study, supports the concept that dysmetabolism is a strong determinant of liver injury. Based on our data, a reduction of the standard upper limit of normal alanine aminotransferase should be considered for older subjects.
Copyright © 2014 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Elderly; Liver enzymes; Non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2014        PMID: 24953204     DOI: 10.1016/j.dld.2014.05.021

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  10 in total

1.  Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival.

Authors:  Umberto Vespasiani-Gentilucci; Antonio De Vincentis; Luigi Ferrucci; Stefania Bandinelli; Raffaele Antonelli Incalzi; Antonio Picardi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

2.  Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.

Authors:  George Boon-Bee Goh; Mangesh R Pagadala; Jaividhya Dasarathy; Aynur Unalp-Arida; Rish K Pai; Lisa Yerian; Amer Khiyami; Achuthan Sourianarayanane; Ruth Sargent; Carol Hawkins; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2015-02-24       Impact factor: 3.199

Review 3.  Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review.

Authors:  Shadi Kolahdoozan; Babak Mirminachi; Sadaf G Sepanlou; Reza Malekzadeh; Shahin Merat; Hossein Poustchi
Journal:  Middle East J Dig Dis       Date:  2020-07

4.  Low Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Yifei Lu; James R Pike; Elizabeth Selvin; Thomas Mosley; Priya Palta; A Richey Sharrett; Alvin Thomas; Laura Loehr; A Sidney Barritt; Ron C Hoogeveen; Gerardo Heiss
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

5.  High Aspartate Aminotransferase/Alanine Aminotransferase Ratio May Be Associated with All-Cause Mortality in the Elderly: A Retrospective Cohort Study Using Artificial Intelligence and Conventional Analysis.

Authors:  Kei Nakajima; Mariko Yuno; Kazumi Tanaka; Teiji Nakamura
Journal:  Healthcare (Basel)       Date:  2022-04-02

6.  Treatment effect of a flavonoid prescription on duck virus hepatitis by its hepatoprotective and antioxidative ability.

Authors:  Yun Chen; Ling Zeng; Yu Lu; Yulan Yang; Meiyun Xu; Yixuan Wang; Jiaguo Liu
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

7.  Serum alanine aminotransferase activity and risk factors for cardiovascular disease in a Caucasian population: the Tromsø study.

Authors:  Svein Ivar Bekkelund
Journal:  BMC Cardiovasc Disord       Date:  2021-01-13       Impact factor: 2.298

8.  Factors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without Hypertension.

Authors:  Sabelo Bonginkosi Dlamini; Ming-Tsang Wu; Hans-Uwe Dahms
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614

9.  A Cross-Sectional Study of the Relationship between Serum Creatine Kinase and Liver Biochemistry in Patients with Rhabdomyolysis.

Authors:  Andy K H Lim; Chitherangee Arumugananthan; Corinne Lau Hing Yim; Lucy J Jellie; Elena W W Wong; Ralph K Junckerstorff
Journal:  J Clin Med       Date:  2019-12-28       Impact factor: 4.241

10.  Association of body mass index with serum alanine aminotransferase in Chinese adolescents: a school-based cross-sectional study.

Authors:  Zan Ding; Jing Zhang; Chang-Yu Deng; Ying-Bin You; Hua Zhou
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-08-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.